Regulatory Notes From Turkey: Imports Grow, Vaccines JV Formed
This article was originally published in PharmAsia News
Executive Summary
In a comprehensive report on the Turkish pharmaceutical sector, the Ministry of Health says that the share of imported drugs in the market has reached 54%, and warns that pricing and reimbursement policies work against locally manufactured products. Meanwhile, the Turkish Pharmacists’ Union, which is the only association authorized to import unavailable drugs for individual patients, looks set to overtake the market leading pharmaceutical company in annual turnover.